TODD HUTTON: Open Payments
NPI 1760535959 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,293 in 53 payments from 10 companies in 2025. Trend: 2023 $8,981 · 2024 $4,317 · 2025 $10,293
Speaker / faculty: $8,383Food & beverage: $1,432Travel & lodging: $479
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 10 | $9,135 |
| ABBVIE INC. | 16 | $326 |
| Janssen Pharmaceuticals, Inc | 6 | $322 |
| Otsuka America Pharmaceutical, Inc. | 7 | $188 |
| Corium, LLC | 5 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, SPRAVATO, REXULTI, Azstarys, CAPLYTA, COBENFY, HETLIOZ.
Industry payments across CA — which companies pay providers there.
